ropinirole has been researched along with Sensitivity and Specificity in 8 studies
Sensitivity and Specificity: Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ropinirole is a nonergoline dopamine D(2)-receptor agonist and has been proven to be effective in both monotherapy and combination therapy for idiopathic Parkinson's disease." | 2.73 | The effect of Madopar on the pharmacokinetics of ropinirole in healthy Chinese volunteers. ( Bi, LL; Chen, XY; Jia, YY; Luo, XX; Wen, AD; Zhong, DF, 2007) |
| " This novel method has been applied to a pharmacokinetic study of RPR in humans." | 1.35 | Highly sensitive method for the determination of ropinirole with a lower limit of quantitation of 3.45 pg/mL in human plasma by LC-ESI-MS/MS: application to a clinical pharmacokinetic study. ( Bharathi, DV; Hotha, KK; Jagadeesh, B; Kumar, SS; Lakshmi, RN; Mullangi, R; Naidu, A, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bharathi, DV | 1 |
| Jagadeesh, B | 1 |
| Kumar, SS | 1 |
| Lakshmi, RN | 1 |
| Hotha, KK | 1 |
| Naidu, A | 1 |
| Mullangi, R | 1 |
| Morrish, PK | 1 |
| Whone, AL | 1 |
| Bailey, DL | 1 |
| Remy, P | 1 |
| Pavese, N | 1 |
| Brooks, DJ | 1 |
| Badarny, S | 1 |
| Stern, A | 1 |
| Susel, Z | 1 |
| Honigman, S | 1 |
| Hocherman, S | 1 |
| Wen, AD | 1 |
| Jia, YY | 1 |
| Luo, XX | 1 |
| Bi, LL | 1 |
| Chen, XY | 1 |
| Zhong, DF | 1 |
| Onal, A | 1 |
| Cağlar, S | 1 |
| Aydoğmuş, Z | 1 |
| White, IR | 1 |
| Bamias, C | 1 |
| Hardy, P | 1 |
| Pocock, S | 1 |
| Warner, J | 1 |
3 trials available for ropinirole and Sensitivity and Specificity
| Article | Year |
|---|---|
A technique for standardized central analysis of 6-(18)F-fluoro-L-DOPA PET data from a multicenter study.
Topics: Algorithms; Antiparkinson Agents; Canada; Dihydroxyphenylalanine; Dopamine Agents; France; Germany; | 2004 |
Effect of ropinirole on visuo-motor test in newly diagnosed Parkinson's disease patients.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Disability Evaluation; Dose-Response Relations | 2006 |
The effect of Madopar on the pharmacokinetics of ropinirole in healthy Chinese volunteers.
Topics: Adult; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Asian People; Benserazide | 2007 |
5 other studies available for ropinirole and Sensitivity and Specificity
| Article | Year |
|---|---|
Highly sensitive method for the determination of ropinirole with a lower limit of quantitation of 3.45 pg/mL in human plasma by LC-ESI-MS/MS: application to a clinical pharmacokinetic study.
Topics: Chromatography, High Pressure Liquid; Dopamine Agonists; Humans; Indoles; Male; Sensitivity and Spec | 2009 |
REAL and CALM: what have we learned?
Topics: Antiparkinson Agents; Benzothiazoles; Clinical Trials as Topic; Corpus Striatum; Disease Progression | 2003 |
Spectrophotometric determination of dopaminergic drugs used for Parkinson's disease, cabergoline and ropinirole, in pharmaceutical preparations.
Topics: Cabergoline; Dopamine Agents; Ergolines; Humans; Hydrogen-Ion Concentration; Indoles; Parkinson Dise | 2007 |
Highly sensitive and selective spectrophotometric and spectrofluorimetric methods for the determination of ropinirole hydrochloride in tablets.
Topics: Acetonitriles; Benzofurans; Borates; Buffers; Calibration; Chloroform; Dopamine Agonists; Hydrogen-I | 2008 |
Randomized clinical trials with added rescue medication: some approaches to their analysis and interpretation.
Topics: Activities of Daily Living; Antiparkinson Agents; Bromocriptine; Humans; Indoles; Levodopa; Multicen | 2001 |